Connect with us
NurExone Biologic Inc.’s nomination for the 2025 Prix Galien Bridges Award places it alongside Roche and Novo Nordisk, highlighting its rising global visibility. Its exosome-based regenerative...
Roche's CE Mark-approved cobas Mass Spec offers automated, standardized mass spectrometry for over 60 tests, improving care for breast cancer and hormonal therapy patients. It aids...
Roche is acquiring Poseida Therapeutics for up to $1.5 billion, emphasizing its strategic focus on innovative allogeneic CAR-T cancer therapies. Poseida’s candidate P-BCMA-ALLO1 shows promise in...
BaseLaunch, a Basel biotech incubator, gains support from AbbVie, joining Roche, Novo Nordisk, Johnson & Johnson, and CSL Behring. Operated by Basel Area Business & Innovation,...
Roche is set to acquire Carmot Therapeutics, along with three clinical-stage assets for treating obesity and diabetes, for a maximum of €2.85 billion. The agreement involves...
Roche recently partnered with Alnylam for the development and commercialization of a treatment for hypertension in patients with high cardiovascular risk. The Swiss company makes an initial...
In total, the world's five hundred largest family companies together generate $8.02 trillion and employ 24.5 million people worldwide. These 500 companies are growing twice as...
Novartis has the worst rating in the European pharmaceutical industry, while AstraZeneca downgrades its expectations from exceptional to neutral. Credit Suisse has also analyzed the Spanish...
Roche will be the company to distribute reagents in Soria. According to the budget application, the amount for the supply of reagents in 2021 amounts to...
The Swiss-based drugmaker Roche has bought the U.S. company, GenMark Diagnostics which specializes in molecular diagnostic tests that are designed to detect multiple pathogens. The Swiss...